SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

03 Aug 2023 Evaluate
The revenue slipped marginally during the June 2023 quarter. A decline of about Rs. 229.35 millions was observed as compared to Rs. 235.06 millions during the corresponding quarter last year.The Company has registered profit of Rs. 24.69  millions for the quarter ended June 2023, a growth of 7.63%  over Rs. 22.94 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 41.45 millions from 38.42 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 229.35 235.06 -2.43 229.35 235.06 -2.43 957.49 750.74 27.54
Other Income 0.12 1.53 -92.16 0.12 1.53 -92.16 2.38 1.84 29.35
PBIDT 41.45 38.42 7.89 41.45 38.42 7.89 184.46 164.39 12.21
Interest 0.16 0.47 -65.96 0.16 0.47 -65.96 1.33 4.54 -70.70
PBDT 41.29 37.95 8.80 41.29 37.95 8.80 183.13 159.85 14.56
Depreciation 8.31 7.30 13.84 8.31 7.30 13.84 32.33 32.81 -1.46
PBT 32.98 30.65 7.60 32.98 30.65 7.60 150.80 127.04 18.70
TAX 8.29 7.71 7.52 8.29 7.71 7.52 37.45 34.90 7.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.50 1.45 -134.48
PAT 24.69 22.94 7.63 24.69 22.94 7.63 113.35 92.14 23.02
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 18.07 16.34 10.57 18.07 16.34 10.57 19.26 21.90 -12.02
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×